
Venture capital · Est. 2014
Delos Capital
Delos Capital is a life sciences venture investor with offices in Cambridge, MA and Hong Kong, backing biotech and medtech companies from founding onward.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Delos Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Delos Capital joined, from press and the firm’s own posts.
Every round Delos Capital joined
Round sizes, Delos Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Delos Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Delos Capital
Events where Delos Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Delos Capital is based in George Town, Cayman Islands. It also has offices in Cambridge and Hong Kong.
In 2014.
3 fund vehicles are on public registers (SEC adviser filings), including DELOS CAPITAL FUND III, LP, DELOS CAPITAL FUND II, L.P. and DELOS CAPITAL FUND, L.P.
Sectors: Life sciences. From the firm’s own website.
Delos backs visionary life sciences teams by linking cutting-edge science to clear clinical needs. It combines biology expertise, understanding of unmet medical need and company-building experience, and supports companies at every stage of development. From the firm’s own website.
Delos Capital lists 37 portfolio companies on its website, including Allecra, Alpha-9 Oncology, Altrubio, Antios and AP Biosciences Inc..
Firms whose websites list some of the same companies include Ascenta Capital, RA Capital and 5AM Ventures.
Know before Delos Capital’s next round is announced.
PRO tracks Delos Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.